Service usage and vascular complications in young adults with type 1 diabetes

BMC Endocrine Disorders

Table 4 Predictors of hypertension, nephropathy and any vascular complication (hypertension, retinopathy and/or nephropathy)

Predictor	Hypertension			Nephropathy			Hypertension, retinopathy and/or nephropathy
	B	95% CI	p value	B	95% CI	p value	B	95% CI	p value
Any CSII use	1.8	1.2 - 2.7	0.004	1.06	0.54 - 2.08	0.877	1.78	1.19 - 2.64	0.005
Male	1.42	0.97 - 2.08	0.069	0.58	0.28 - 1.03	0.062	1.16	0.8 - 1.68	0.424
Mean HbA1c ≥ 8%	1.42	0.96 - 2.09	0.077	3.59	1.67 - 7.74	0.001	1.64	1.13 - 2.38	0.01
Smoking	1.34	0.91 - 1.96	0.135	1.2	0.63 - 2.29	0.572	1.3	0.9 - 1.88	0.17
Diabetes duration	1.05	1.01 - 1.09	0.006	0.99	0.93 - 1.06	0.831	1.05	1.02 - 1.09	0.003
Metropolitan residence	0.92	0.63 - 1.37	0.69	1.184	0.6 - 2.32	0.623	0.97	0.66 - 1.42	0.868
No reported service contact	0.21	0.1 - 0.51	0.001				0.17	0.07 - 0.41	< 0.001
Hypertension	N/A			3.19	1.66 - 6.15	0.001	N/A
Constant	0.16		< 0.001	0.3		< 0.001	0.21		< 0.001
Model Statistics	Chi² = 45.34, df 7, n550, p < 0.001			Chi² = 42.95, df 8, n550, p < 0.001			Chi² = 58.02, df 7, n550, p < 0.001

CSII: Continuous Subcutaneous Insulin Infusion. N/A: Not applicable.
No modelling undertaken for retinopathy independently or analyses of no health service contact as a predictor of nephropathy as too few cases.

ISSN: 1472-6823